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ABSTRACT
Introduction: viral epidemics have presented a risk to human health since they can turn into pandemics 
and affect a large part of the population, especially for poor developing countries. In 2020, the worldwide 
pandemic of COVID-19 is underway. Research is currently being carried out showing data that combines 
genetic and social information that can change our understanding of the dynamics of the epidemic. 
Objective: to describe data science-based technology tool called Nextstrain that allows epidemics to be 
visualized with data as up to date as possible using academic databases. 
Development: there are currently viral sequences from 57 countries on 6 continents. The common ancestor 
of the virus circulating in the world emerged in Wuhan, China, in late November or early December 2019, 
and from where it is supposed to have mutated towards humans, from bats and pangolins. Regarding 
monitoring, research work is already being carried out using this tool, such as in Taiwan, France, and 
Finland, which were able to determine where the SARS-CoV-2 strains that were causing outbreaks in their 
respective country originated. Besides, Nextstrain allows to freely share the phylogenetic analyzes of 
various authors from different countries and allows us to see the great work in the epidemiology of the 
virus.
Conclusions: Nextstrain is a tool based on big data that gives us a better view of the worldwide epidemiology 
of pathogens of interest. Its use is based on bioinformatic tools and it shows us this information through 
a pleasant and understandable ecosystem.
Keywords: Coronavirus Infections; Severe Acute Respiratory Syndrome; Betacoronavirus; Genome, Viral; 
Semantic Web.  
Introducción: las epidemias virales han demostrado ser un riesgo para la salud humana, ya que pueden 
convertirse en pandemias y afectar a gran parte de la población, especialmente a los países pobres en 
vías de desarrollo. En este año 2020 la pandemia mundial por la COVID-19 está en marcha. Actualmente 
se están llevando a cabo investigaciones que muestran datos que combinan tanto la información genética 
como la social, las cuales pueden cambiar nuestra comprensión acerca de la dinámica de la epidemia. 
Objetivo: describir la herramienta tecnológica basada en la ciencia de datos, denominada Nextstrain, 
que permite visualizar las epidemias con los datos más actualizados en tiempo real, utilizando las bases 
de datos académicas. 
Desarrollo: actualmente hay secuencias virales de 57 países en 6 continentes. El antepasado común 
del virus que circula en el mundo surgió en Wuhan (China), a finales de 2019, y desde donde se supone 
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que ha mutado hacia los seres humanos a partir de murciélagos y pangolines. En lo que respecta al 
seguimiento, se han realizado trabajos de investigación con este instrumento en países como Taiwán, 
Francia y Finlandia, que han podido determinar el lugar de origen de las cepas del SARS-CoV-2 que causan 
los brotes en sus respectivos países. Nextstrain permite compartir libremente los análisis filogenéticos de 
varios autores de diferentes países, así como analizar el amplio trabajo realizado sobre la epidemiología 
del virus. 
Conclusiones: Nextstrain es una herramienta creada a partir de grandes bases de datos que brinda una 
mejor visión acerca de patógenos de interés para la epidemiología mundial. Su uso se apoya en herramientas 
bioinformáticas y muestra esta información a través de un entorno agradable y comprensible. 
Palabras clave: Infecciones por Coronavirus; Síndrome Respiratorio Agudo Grave; Betacoronavirus; 
Genoma Viral; Web Semántica
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INTRODUCTION
The emerging viral epidemics represent a risk for human health, which may turn into pandemics affecting a 
large part of the population, especially in developing countries(1). In 2019, a new coronavirus arose in Wuhan, 
province of Hubei, China, this virus is named SARS CoV-2, causing a severe acute respiratory syndrome, and 
spreading rapidly to other parts of China and currently in approximately 200 countries worldwide(2). 
This coronavirus belongs to the Coronaviridae family ordered by Nidovirales, with a positive-sense single-
stranded RNA and a genome of approximately 30 kilobases with a variable number of open reading frames, 
composed of 10 proteins(3). The main form of transmission of the viruses is through direct contact from person 
to person, as well as through respiratory drops produced when an infected person touches the starling(4). Seven 
types of coronaviruses affecting humans have been identified: HCoV-NL63, HCoV-229E, HCoV-OC43, HCoV-HKU1, 
SARS-CoV, MERS-CoV and SARS-CoV-2, can cause a severe respiratory syndrome in humans as well as four others 
causing mild illnesses of the upper respiratory tract(5). 
Through phylogenetic analysis, it has been determined that SARS-CoV-2 is related to coronaviruses derived from 
bats that share an 87,99 % sequence identity with the SL-CoVZC45 and 87,23 % with the SLS-CoVZXC2, as well as 
SARS-CoV y MERS-CoV the 79 % and 50 % sequence identities respectively(6). Nextstrain is developing innovative 
databases showing data that combine genetic, social information for a better understanding the dynamics of 
the epidemic, yet there is no cohesion in the isolated bell(7). These data from different studies are not properly 
disseminated among the public in the academic and many times are not used in public policies of governments.
Various areas are in progress such as genomics and computing, transforming researchers’ ability to respond to 
epidemic outbreaks in recent years(8). Also, since next-generation sequencing technologies are more efficient 
and less costly than a few years ago, large-scale sequencing of entire genomes is becoming a tangible reality(9). 
Therefore, this should go hand in hand with rapid and efficient dissemination of results in real-time. The speed 
in generating the genome sequences of various pathogens has vastly improved the ability to better understand 
past epidemics and generate public health interventions in a population(8).
A modern technology platform that we have of support based on data science is called Nextstrain (http://
nextstrain.org) that allows visualizing the phylodynamic and evolutionary profile of epidemics with updated 
data in real-time using various public databases of virus genomic sequences through genomic epidemiology(10). 
Nextstrain consists of data analysis and visualization components from public repositories: NCBI (National 
Center for Biotechnology Information) (www.ncbi.nlm.nih.gov), GISAID (Global Initiative Sharing All Influenza 
Data) (www.gisaid.org), ViPR (Virus Pathogen Database and Analysis Resource) (www.viprbrc.org), GitHub, and 
other sources in real-time. This tool performs phylodynamic analyzes, which can be used for epidemiological 
surveillance with molecular sequences, temporal and geographic origins, in addition to evolutionary history and 
ecological risk factors(11). Nextstrain has built-in phylogenetic analysis tools such as TreeTime, which provides a 
tree where all clades are scaled so that the positions of the terminal nodes correspond to their sampling times, 
and the internal nodes are located at the most probable moment of divergence(12).
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This article wants to describe data science-based technology tool called Nextstrain that allows epidemics to be 
visualized with data as up to date as possible using academic databases. 
DEVELOPMENT
SARS-CoV-2 phylogenetic clade based temporal and spatial visualization tool 
The phylogeny currently shown in Nextstrain, has the city of Wuhan, China as the origin of the new 
coronavirus SARS-CoV-2, possibly in November-December 2019. There is uncertainty regarding the date 
estimates and the reconstruction of the geographic spread since patterns are only a hypothesis. Site 
numbering and genome structure use Wuhan-Hu-1/2019 as a reference. Phylogeny originates from the 
earliest samples from Wuhan. The virus has spread to various countries of the world, currently reaching 
188 regions and countries worldwide. In this brief review, we use Nextstrain to learn some relevant details 
about the spread of the SARS-CoV-2 virus in time and space in different countries of the world.
The Nextstrain platform has three panels to be able to extract data from the beginning of the replacement 
of the first genome to the last ones deposited until the current date of this revision. Among the functions 
that generate relevant information, it is to make groupings based on certain characteristics of the 
phylogenetic algorithm, in this case, clades, mutations, as well as other functions based on geography 
such as countries, regions, and less relevance by the author per laboratory, etc. For the following analysis, 
we use clustering based on clades generated through the Nextstrain phylogenetic algorithm. So far, five 
clades have been reported (19A, 19B, 20A, 20B, 20C) distributed in the different countries that have 
reported their viral genomes in public databases (Figure 1).
Figure 1. Phylogenetic tree of the expansion of the five clades reported on the Nexstrain platform. The 
images show how the virus originates in Wuhan, China (A), through Clade 19A, then clades 19B, 20A and 
20C (B) appear, figure C shows how clade 20A begins to show dominance in the tree, finally D is almost 
the current scenario where viruses belonging to clades 20A, 20B and 20C are reported in most countries. 
Adapted from Nexstrain
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The first genome reported in Nextstrain was the original 26/12/2019 (EPI_ISL 406798) of the city of Wuhan, 
China (Figure 1A), reported by Chen et al(13). The chronological order in which the clades appeared is as 
follows, the first clade that is exhibited is the pioneer clade 19A, followed by the second appearance on 
01/12/2020 reporting clade 19B. The third clade to appear is 20A on 02/03/2020 in England. Finally, the 
last clade to emerge was 20C dated 02 16 2020.
The distribution of the phylogenetically generated clades worldwide through Nextstrain (Figure 2) shows 
effectively that the most widespread clade worldwide is the 20A and 20B clades, this is according to the 
genomes that are on the platform. However, it gives us clear lights that, is the clade that has a greater 
world distribution at present.
Figure 2. Distribution of phylogenetically generated clades of the SARS-CoV-2 virus across the continents.
Analysis through space and time, the virus originating in China begins its phase of expansion to Europe, 
neighboring Asian countries, and Australia (Figure 3A), then its expansion stage is to the United States 
where clades 19A and 19B are reported on the day 26/12/2019 and 13/01/2020 respectively. In China 
(Shenzhen), clade 19B is reported on 13/01/2020. In Europe, in England report clade 20A on 03/02/2020. 
England reported clade 20B on 16/02/2020. The last clade to appear is 20C on 16/02/2020, in Singapore 
as well.
Figures 1 and 3 show the events in time and space, generating a screenshot of four moments, of the 
different days of the pandemic worldwide on different dates. Although clade 19A has been the pioneer 
in Wuhan, clades 20A and 20b are practically are practically circulating in a large number of countries on 
the five continents (Figure 2), and according to the figure it is the clades with the highest spread, then 
it was introduced to Italy from where it has been disseminated to different countries in Europe, Asia and 
the United States (Figures 3B and 3C). Even though the other clades have also been reported in other 
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countries, their dissemination has not been as effective as that of clade 20A, also followed by clade 20B. 
The least distributed clade is 19B, it is interesting to know why it was not widely disseminated, reported 
in the United States, interestingly without mutations.
We also show the following from January to early February 2020, the second month of the epidemic, the 
appearance of introductions is observed beginning with individual cases in North America, Europe, and 
Oceania (Figure 3B). Since the spread of the SARS-CoV-2 virus began to the rest of the world, specifically 
in North America and Europe, the community transmission is evident in Europe, North America, and 
Oceania (Australia). Likewise, the creation of a European node where it spread throughout Europe in early 
February, in the third month the North American node is created. The spread to Latin America was from 
countries in Europe and North America and in addition to the African continent in March, Figure 3C. This 
explains the various intercontinental introductions during this period, indicating a mix of various viral 
lineages, shown in five final clades thus far, Figure 3D. Interestingly, figure 3 shows the total expansion 
from east to west, then south and north, this is due to the migratory movement of different tourists at 
the beginning of the pandemic.
Figure 3. Expansion of the SARS-CoV-2 virus across the continents. This display by dates is done in 
Nextstrain by the date range function. Each image shows how the virus spread from its origin in China: (A) 
As of January 15, it begins to spread, entering Europe, Australia and countries close to China (B) Relevant 
is the introduction to the United States and new introductions to Europe (C) The various introductions of 
the virus in South America are beginning to be seen (D) The distribution of the virus is completely on all 
continents shown in a complex network. Adapted from Nextstrain.
Besides, we show a figure 4 with the genomes written down for each week since the start of the pandemic. 
The frequency distribution presents high bars on March and the beginning of April, where there are the 
dates when the genomes have been sent to the most that contribute to the release of information to face 
the novel coronavirus. United States and Spain, followed by China and the United Kingdom, which have 
sent the most sequences up to the moment of this analysis.
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Figure 4. Distribution of the SARS-CoV-2 genomic sequences shown in the Nextstrain platform repository. 
The data is shown every week from the beginning of the genome deposits.
Surveillance and distribution of the SARS-COV-2 based on Nextstrain and literature review
The Nextstrain tool shows three main panels, being the phylogenetic tree panel, the geographical panel 
with the world map, and a panel showing the entropy of the virus in its entire sequence (30 kb). 
Each panel presents various manipulation options to be able to extract data according to the search 
strategy. Likewise, there is real-time monitoring of how mutations are occurring in different viruses from 
different regions and places, in addition to the generation of new clades within the phylogenetic tree. 
Through the formation of clades or groups, the origins of the viruses that were brought and introduced 
by travelers from different parts of the world can be associated.
Nextstrain-based association studies and supporting scientific literature are shown below. A study 
conducted in Taiwan, where a patient with the SARS-CoV-2 virus whose source of infection was unknown 
is presented. Later the source of infection was revealed with the help of phylogenetic analysis of the 
isolated virus, and together with data to help with epidemiological information, they indicated that the 
66-year-old patient traveled to Dubai from January 29 to February 10, 2020, then to Egypt from February 
11 to February 21, 2020. In Egypt, he participated in an eight-day sightseeing trip on a Nile River cruise. 
He returned to Taiwan via an international airline on February 21, 2020, from February 18, 2020, began 
to suffer from symptoms. Additionally, it was reported that 16 other people in the same tour group had 
similar symptoms at the time, showing positive results for the novel coronavirus.
Genome sequencing was performed to isolate the SARS-CoV-2 virus (NTU03) from a throat swab collected 
on March 2, 2020. The NTU03 sequence was grouped with clade 20A sequences showing 5 nucleotide 
differences, these included two synonymous mutations (between Orf 1b and 5410 and between orf 3a 
and 819), two non-synonymous mutations (between Orf 1b and 799 and between orf 3a and 57), and 
a mutation within the 5’UTR region. Likewise, an average of 12 nucleotide differences was observed 
between NTU03 and sequences within other clades. The phylogenetic analysis concludes that the NTU03 
sequence belongs to clade 20A. Through the results obtained from the SARS-CoV-2 (NTU03 sequence), 
virus genome and its phylogenetic analysis, Taiwan patients, who tested positive for SARS-CoV-2 virus, 
spread the virus across Europe, supported by the information provided by the laboratories that submitted 
the virus sequences to the Global Influenza All Data Sharing Initiative (GISAID)(14).
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In another study, the first European cases of SARS-CoV-2 were analyzed, of which six genomes were 
associated with a group of transmissions in the French Alps in late January 2020. Of the six patients 
who tested positive for SARS -CoV-2, the three samples with the highest viral loads were selected for 
analysis. A nasopharyngeal swab was collected from a patient on February 7 (sample 1) and the other two 
samples were collected from the same asymptomatic patient on February 8 and 9 (sample 2 and sample 
3). Comparison with the reference SARS-CoV-2 virus (NC_045512), it was possible to identify a deletion 
of three nucleotides in the open reading frame 1a (ORF1a) at genomic positions 1607 and 1609. It is 
important to highlight that this deletion was also identified in all the readings of sample 1 and 3. Using 
the CoV-GLUE resource, this mutation was found to lead to the deletion of amino acid 268 in nonstructural 
protein 2 (nsp2). This deletion in nsp2 (Asp 268) was also characterized in 37 of 571 complete genome 
sequences. Phylogenetic analysis based on the entire genome found 15 strains containing this specific 
deletion, they were relatively close to the strains isolated in China between December 2019 and the 
beginning of February 2020. While 23 strains with this deletion collected in the Netherlands have slightly 
diverged. However, longitudinal samples from the asymptomatic patient (Sample 2 versus Sample 3) 
were compared using a minimum depth of coverage of 100x to make a preliminary assessment of genetic 
variability within the host. Three SNVs are exhibited between the two samples: C366A (between nsp1 
and S34Y), A20475G (synonymous mutation in nsp15), and T24084A (between protein S and L841H), 
suggesting the evolution of the virus within the host(15).
A third study of SARS-CoV-2 virus isolated from reported patient zero from Finland showed a nucleotide 
substitution C21707T compared to the reference strain from Wuhan China in December 2019 (NC_045512), 
which has led to a substitution of histidine to tyrosine (H49Y) in the N-terminal domain of the N domain 
of the spike glycoproteinor S protein .The genome sequence of the Finnish patient was almost identical 
to the Wuhan reference strain, indicating an early introduction from China(16).
Something to consider is the versatility to be able to work within Nextstrain and to be able to extract 
information from various mutations that occur in the different genomic sequences, they are synonymous 
and non-synonymous nucleotide and amino acid mutations, divergence rates, date and clade. Observing 
the various studies, the importance of this platform can be seen as an essential current tool to fight the 
SARS-Cov-2 pandemic, mainly in the study of geographic distribution, association studies in clades, rates 
of virus evolution through in time and space.
A model for epidemiological surveillance using genomic virus data
Nextstrain is a platform that mixes genetic data with epidemiological data to generate a dynamic 
visualization of the virus circulating in different regions at the beginning of epidemic or pandemic 
outbreaks. It uses public primary databases as support to generate evolutionary data through phylogeny 
and phylogenomic. Mutations that arose in the different genomic regions of the SARS-CoV-2 virus, such as 
mutations of the Spike protein, ORFa, ORFb and ORF14 in the different countries, and associating them 
with the pathogenicity and infectivity of the virus, from December 2019 to July 2020.
To know the distributions of SARS-CoV-2 sequences, throughout the world, we use the GISAID repository, 
which is the supporting database for Nexstrain.
As of July 7, 60,742 genomes had been sampled worldwide, with Europe being the continent that has 
reported the most genomes with 38,280 followed by North America (12,574) South America (1,057), 
Oceania (2,601), Asia (5,381) and Africa (836). In South America, Brazil is the one that reported the 
most with 630 genomes, followed by Chile with 167 and Colombia along with Uruguay with 126 and 74, 
respectively(10). Therefore, Nexstrain and GISAID are useful for the scientific community, since it does not 
only allows us to see the distribution and evolution of SARS-CoV-2 in real-time but also helps to carry a 
report generated through scientific work done by country, by an institution and even in hosts the virus 
has been isolated. Data are shown in Figure 5.
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Role of genomic epidemiology in Peru
At this time with no global presence, innovation in science plays an important role in tackling this global 
public health problem caused by the outbreak of the novel SARS-CoV-2 coronavirus. Therefore, countries 
with high budgets in science and technology are leading and dealing with high-impact research and producing 
large amounts of genomic data to understand the epidemiology and evolution of the virus globally in the short 
term. However, it is not a distant problem to countries in South America and Africa, where smaller amounts of 
genomic sequences of the SARS-CoV-2 virus are reported (Figure 5). Likewise, countries such as Venezuela and 
Peru are not oblivious to this reality, where only 2 and 1 genome, respectively, have been reported, deposited 
in GISAID, and displayed in Nextstrain.
Figure 5. Number of genomes sequenced by continent to date
In the case of Peru, the reported data is insufficient to be able to obtain conjectures of the possible 
genotypes that are currently circulating in the different regions of Peru, in addition to studying possible 
unique mutations of strains that are circulating in the regions and associating them with their rate of 
lethality. Other questions to answer are how many introductions of the virus occurred in Peru, it is 
the same strain of the SARS-CoV-2 virus that is in all the regions with the highest incidence, such as 
departments such as Callao, Loreto, Piura, and Lambayeque. Although a SARS-CoV-2 strain was recently 
almost completely sequenced from an oropharyngeal swab from a Peruvian COVID-19 patient who had 
returned from Italy, the entire genome has 29,856 base pairs, the phylogenetic analysis indicates it is 
grouped in clade G (variant G), however, it is found in clade 20A according to the Nextstrain grouping, 
which coincides with other cases in South America, such as Brazil, Colombia, Chile, Argentina and 
Uruguay. Furthermore, some mutations in coding regions have been found that generated amino acid 
variations such as 1433P, P4720L, and D6909G in the polyprotein encoded by the orf1ab gene, also D614G 
in the S glycoprotein(17). This introduction of the virus comes from Europe (Italy and Luxembourg) and has 
been expanding for now according to data in Lima, we need to deepen our efforts for the sequencing of 
genomes and to know what the current distribution of the virus is like in Peru and how it is distributed 
after almost six months.
Studies framed in this subject are of crucial impact to generate public health policies in each country, 
adapting their plans and fighting the pandemic in our region and the different countries of South 
America. Therefore, the Nextstrain platform for epidemiological surveillance is crucial during and after 
the pandemic to locate possible outbreaks in a period of intelligent isolation. After the quarantines have 
been removed in different places, the virus will continue to circulate with its various strains in various 
countries. According to reports, this would happen as long as we do not have the vaccine until possibly 
2022, therefore, we insist on improving the genomic epidemiological surveillance systems to know and 
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understand the transmission of the virus within the following years in both the South American region 
and especially in Peru.
Knowing the interior of the nextstrain platform
Nextstrain is a computer project with free access to different researchers, both bioinformatics and data 
science(10). All the documentation is in the open-source repository called Github (https://github.com/), 
being the place of construction for software developers as well as data exchange for the scientific data 
community. Here in this database three repositories are the fundamental basis of the Nextstrain platform 
(https://github.com/nextstrain), being the following Sponsors, http://www.nextstrain.org and Augur.
The sponsor is the software to display an interactive visualizations of genomic cutting-edge data. The 
software can be downloaded and used locally on your computer or used through the website http://
www.nextstrain.org. It is a software written in the java language and is in version 2 to be used through 
the following installation tutorial (https://nextstrain.github.io/auspice/introduction/how-to-run). 
Likewise, http://www.nextstrain.org is the website to help the public health and scientific community 
to obtain data on emerging pathogens such as the Dengue virus, influenza, SARS-CoV-2. The site is 
constantly updated on public display of data with analytical tools for community use.
The third software is Augur, which is the core part of the Nextstrain ecosystem for building phylogenetic 
trees pathogens. The source code is also in the Github repository. Augur provides a collection of 
commands to perform common bioinformatics tasks that are designed to be compostable in the pipeline 
for longer runs. Augur needs external tools for multiple sequence alignments of viral genomes using the 
MAFFT software (https://mafft.cbrc.jp/alignment/software/), in addition to the phylogenetic inference 
of the trees shown on the website, uses the maximum likelihood inference method, through the IQ-Tree 
software (http://www.iqtree.org/). 
Augur outputs are a series of text files, which can be viewed through Auspicia. It presents its tutorial 
for consulting the different internal commands (https://nextstrain-augur.readthedocs.io/en/stable/
usage/cli/cli.html).To face the pandemic, the platform created a new hcov-19 project available (http://
nextstrain.org/ncov) to house the data from the SARS-CoV-2 virus genomics project. The data was shared 
and extracted via GISAD, which is submitted by the different authors and laboratories, on which this 
research is based. Here in this tool, we can analyze our information as input. We need two files: the 
genetic data in FASTA format and our metadata in TSV format. The table format consists of 23 columns 
of the genome data per sample. The team that forms Nextstrain is made up of six developers who keep 
the platform updated and above all that it is free without cost (open access). Furthermore, the platform 
uses three Python programming languages, shell, JavaScript, for its various programs contained in its 
pipeline.
The source and support that provides the genomic data
GISAID, is a German repository, which was created as an innovative political effort to promote the 
international exchange of genetic data and viruses associated with influenza(18). However, this database in 
epidemic outbreaks and efficient way to share data generated by various laboratories on the 5 continents 
and to be useful to the scientific community and global health policies in this event of COVID-19. GISAID 
has played an important role since previous pandemics such as in 2008 in Indonesia caused by the H5N1 
strain, then in 2009 by the H1N1 outbreak in the United States. Likewise, China reported in 2013 the 
H7N9 flu outbreak, sequenced the same day, and submitted it to the database.
GISAID is currently a great contribution to global health, highlighting the following: it is a collated 
repository of high-quality influenza sequences, facilitating the rapid exchange of virus data in the event 
of a possible pandemic, establishing trust in low-income countries is key to pandemic preparedness. 
Currently, the GISAID base has created a repository to host the genomic sequences of the SARS-CoV-2 
virus that is currently causing a pandemic outbreak. The objective is to share in real-time the genomic 
sequences for research by the scientific community. Furthermore, which is the support for a Nextstrain 
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interactive web server, GISAID currently contains 60 741 genomic virus sequences, of which 38 878 are of 
high coverage. The phylogenetic tree presented is based on markers that are variants such as S, O, L, V, 
G, GH, GR, and other clades. Also, it has metadata of the epidemiology of the sample, origin, date, sex, 
sequencing technology, among others.
Sequencing technologies used for the study of genomic epidemiology
The success of rapid detection, monitoring, and tracking of the novel SARS-CoV-2 virus in real-time 
worldwide, all this success has been thanks to the support, also of next-generation sequencing 
technologies (NGS). NGS, or also called parallel mass sequencing, has been developed in recent years 
and allows the sequencing of millions of DNA fragments. Currently, the use of NGS has almost completely 
replaced conventional Sanger sequencing and has many applications(19). For example, these sequencing 
technologies are being used in the identification of new emerging viral pathogens such as recently in a 
Zika outbreak in Brazil(20).
Among the various platforms for genetic sequencing is Oxford Nanopore - MinION this device is a miniature 
sequencer that contains 512 nanopores, responsible for detecting single-stranded DNA, until now the 
use of this tool has focused on DNA sequencing, however it has been exploring its application in the 
analysis of RNA and proteins, it has been applied in sequencing and bacterial identification works, until 
the recent finding of its efficacy in detecting pathogens in plasma(21). The Illumina HiSeq platform uses 
sequencing using synthesis technology in which fluorescent, market reversible terminator nucleotides 
bind to growing DNA strands and images are obtained through their excitation by fluorochrome at the 
point of attachment, this tool gives a true base-by-base sequence that practically eliminates errors(22).
Most of the SARS-CoV-2 virus sequencing projects have used the two technologies mentioned above, 
proof of which many genomes have high coverage or full coverage. It is important to have high-quality 
sequencing for bioinformatics and phylogenetic analysis such as substitution rate, virus variants, 
synonymous and non-synonymous mutations. Some patterns associated with virulence strains could be 
elucidated, so sequencing with a low error rate is important.
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CONCLUSIONS
Nextstrain is a tool based on big data that gives us a better view of the worldwide epidemiology of 
pathogens of interest. It is shown that it is the support for different people both of researchers with 
computer skills, as well as those trained in aspects of public health and health policy. Furthermore, it 
is a source of continuous monitoring of the movement and outbreaks of the virus in various countries, 
with an emphasis on those with little scientific and technological capacity. Finally, Its use is based on 
bioinformatics tools and shows us this information through a pleasant and understandable ecosystem.
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